Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Sharpens the Axe

NEW YORK, Oct. 10-Pyrosequencing has let go 23 staffers in its Uppsala, Sweden headquarters, the genetic analysis equipment company said today.


Staff were cut in order to "accelerate the route to profitability," the company said in a statement. The move is expected to reduce costs by $7 million next year.


Other targets for the company's cost reduction program include administration, product development and central marketing.


Pyrosequencing now employs 145 globally, including 110 employees in Uppsala.


The company's produces include bench-top and high-throughput DNA analysis and sequencing systems. For more information, see the company website.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.